Slideshow

Osteoporosis: 3 Things to Know

Author(s):

Drawbacks of bisphosphonate holidays, bone benefits of the Mediterranean diet, and a new weapon against glucocorticoid-induced osteoporosis.

References1. Bindon B, Adams W, Balasubramanian N, Sandhu J, Camacho P. Osteoporotic fractures during bisphosphonate drug holiday. Endocr Pract. 2018;24:163-169. doi: 10.4158/EP171975.OR.2. Silva TR, Martins CC, Spritzer PM. Mediterranean dietary pattern is positively associated with bone mineral density and lean mass in postmenopausal women: a cross-sectional study. Presented at: ENDO 2018; March 19, 2018; Chicago, Illinois. Abstract MON-301.3. Saag KG, Wagman RB, Geusens P, et al. Denosumab versus risedronate in glucocorticoid-induced osteoporosis: a multicentre, randomised, double-blind, active-controlled, double-dummy, non-inferiority study. Lancet Diabetes Endocrinol. 2018;6:445-454. doi: 10.1016/S2213-8587(18)30075-5.

Related Videos
Uncovering the Role of COVID-19 in Rheumatic Disease, with Leonard Calabrese, DO
Comparing Treatment Options for Psoriatic Arthritis with Philip Mease, MD
Considering Viral Infections in Patients With Rheumatic Disease With Leonard Calabrese, DO
Leonard H. Calabrese, DO, Professor of Medicine and Vice Chair, Department of Rheumatic and Immunologic Diseases, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University
Alvin Wells, MD, PhD: Making Informed Treatment Decisions With New Testing Strategies
Alvin Wells, MD, PhD
Upcoming Research in PsA, AxSpa, with Philip Mease, MD
Philip Mease, MD, Clinical Professor, University of Washington School of Medicine and Director, Rheumatology Research, Swedish Medical Center
© 2024 MJH Life Sciences

All rights reserved.